This trial is testing how safe and effective the Impella ECP device is for people undergoing a high-risk heart procedure.
2 Primary · 4 Secondary · Reporting Duration: through end of study, 30 days
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: Impella ECP · No Placebo Group · N/A
Age 18 - 90 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: